Idexx Laboratories (IDXX) Enterprise Value (2009 - 2026)

Idexx Laboratories has reported Enterprise Value for 18 years, with the latest figure at $41.3 billion in Q2 2026.

• On a quarterly basis, Enterprise Value fell 3.5% year-over-year to $41.3 billion in Q2 2026; TTM through Jun 2026 was $41.3 billion, a 3.5% decrease from a year earlier, with the FY2025 full-year figure at $53.7 billion, up 60.68% from the prior year.
• Enterprise Value was $41.3 billion for Q2 2026 at Idexx Laboratories, down from $44.3 billion in the prior quarter.
• The five-year high for Enterprise Value was $53.7 billion in Q4 2025, with the low at $26.9 billion in Q3 2022.
• Average Enterprise Value over 5 years is $40.3 billion, with a median of $41.4 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Enterprise Value plunged 48.82% in 2022, then jumped 60.68% in 2025.
• Over 5 years, Enterprise Value stood at $33.7 billion in 2022, then soared by 35.39% to $45.6 billion in 2023, then dropped by 26.7% to $33.5 billion in 2024, then soared by 60.68% to $53.7 billion in 2025, then decreased by 23.11% to $41.3 billion in 2026.
• The last three Enterprise Value figures came in at $41.3 billion (Q2 2026), $44.3 billion (Q1 2026), and $53.7 billion (Q4 2025), per Business Quant data.